IDH1 gene mutations: a new paradigm in glioma prognosis and therapy?
CRICM INSERM UMR 975, Biologie des Interactions Neurones-Glie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France. marianne.labussiere@voila.fr
Marianne
M
Labussiere
Marc
M
Sanson
Ahmed
A
Idbaih
Jean-Yves
JY
Delattre
D001932:Brain Neoplasms / Q000201:enzymology / Q000235:genetics* / Q000628:therapy*; D005909:Glioblastoma / Q000201:enzymology / Q000235:genetics / Q000628:therapy; D005910:Glioma / Q000201:enzymology / Q000235:genetics* / Q000628:therapy*; D006801:Humans; D007521:Isocitrate Dehydrogenase / Q000235:genetics*; D017354:Point Mutation; D011379:Prognosis
D007521:Isocitrate Dehydrogenase; C543588:IDH1 protein, human